History beckons for Fremantle, after best-ever fightback propelled them into Grand Final
Sydney will be pondering what could have been, while Fremantle has an eye on history.
Latest articles and price-sensitive announcements with AI sentiment classification.
Sydney will be pondering what could have been, while Fremantle has an eye on history.
Highlights Pharmaxis is an Australian clinical-stage pharmaceutical company focused on developing treatments for inflammatory conditions and fibrosis. The company's LOX inhibitor platform targets the enzyme systems involved in fibrosis the scarring process that underlies conditions including liver cirrhosis and lung fibrosis. Pharmaxis generates commercial revenue from its Bronchitol product for cystic fibrosis and its dry powder technology manufacturing services. Pharmaxis Limited (ASX:PHL)...
other announcement
other announcement
other announcement
director_dealing announcement
other announcement
other announcement
other announcement
other announcement
director_dealing announcement
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement
director_dealing announcement
director_dealing announcement
director_dealing announcement
other announcement
other announcement
other announcement
other announcement
capital_raise announcement
other announcement
director_dealing announcement
director_dealing announcement
other announcement
capital_raise announcement
other announcement